# Bright Minds Biosciences Inc.: Form 20-F for the period ended Sep 30, 2023

- Company: [Bright Minds Biosciences Inc.](/companies/drug.md) (CIK 1827401)
- Form: 20-F
- Filed: 2023-12-29
- Accepted by EDGAR: Dec 29, 2023, 16:30 ET
- Period: 2023-09-30
- Accession: 0001062993-23-023281
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1827401/000106299323023281/form20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1827401/000106299323023281/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2022-10-01 to 2023-09-30 | CAD 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2022-10-01 to 2023-09-30 | −CAD 7.4m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2022-10-01 to 2023-09-30 | −CAD 1.98 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2022-10-01 to 2023-09-30 | −CAD 1.98 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2022-10-01 to 2023-09-30 | −CAD 7.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2023-09-30 | CAD 6.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2023-09-30 | CAD 6.8m | ifrs-full:CurrentAssets |
| Total assets | at 2023-09-30 | CAD 6.9m | ifrs-full:Assets |
| Current liabilities | at 2023-09-30 | CAD 280.9k | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2023-09-30 | CAD 280.9k | ifrs-full:Liabilities |
| Shareholders' equity | at 2023-09-30 | CAD 6.6m | ifrs-full:Equity |
| Shares outstanding | at 2023-09-30 | 4,463,837 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1827401/000106299323023281/form20f.htm

Filed Dec 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001062993-23-023281. Last ingested by Listed: Nov 2, 2026, 18:24 ET. No prices; not investment advice.